SFX by Ex Libris Inc.

Title:	Click chemistry enables preclinical evaluation of targeted epigenetic therapies
Source:	Science [0036-8075] Tyler, D S yr:2017

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hwang, Vicki J. "Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease." Kidney international. 92.4: 922-933.
description	2.	Kiberstis, Paula A. "Old cancer drugs with a modern mechanism." Science 356.6342 (2017): 1041-1042.
description	3.	Winter, Georg E. "BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment." Molecular cell. 67.1: 5-4294967295.
description	4.	Rodriguez, Raphaël M. "Unravelling the genomic targets of small molecules using high-throughput sequencing." Nature reviews. Genetics 15.12 (2014): 783-796.
description	5.	Barbieri, I. "Bromodomains as therapeutic targets in cancer." Briefings in functional genomics 12.3 (2013): 219-30.
description	6.	"Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update." Journal of medicinal chemistry 63.22: 13228-13257.
description	7.	Andrea, R. "Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence." Cancer management and research 10 (2018): 3083-3099.
description	8.	Nowak, Radosław P. "Plasticity in binding confers selectivity in ligand-induced protein degradation." Nature Chemical Biology 14.7 (2018): 706-714.
description	9.	C, Weir C. "Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth." PLoS One 12.7 (2017).
description	10.	Le, Dung T. "Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade." Science 357.6349 (2017): 409-413.
description	11.	Li, W. "Targeting epigenetic regulations in cancer." Acta Biochimica et Biophysica Sinica 48.1 (2015): 1-13.
description	12.	Li, X. "Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD." Human molecular genetics 24.14 (2015): 3982-3993.
description	13.	Guenther, M. "Quantitative ChIP-Seq Normalization Reveals Global Modulation of the Epigenome." Cell Reports 9.3 (2014): 1163-1170.
description	14.	Tin, Mandy M.Y. S. "A first look at the Oxford Nanopore MinION sequencer." Molecular ecology resources 14.6 (2014): 1097-1102.
description	15.	Mortimer, Stefanie A. "Insights into RNA structure and function from genome-wide studies." Nature reviews. Genetics 15.7 (2014): 469-479.
description	16.	Fricke, David F. "Bacterial genome sequencing in the clinic: bioinformatic challenges and solutions." Nature reviews. Genetics 15.1 (2013): 49-55.
description	17.	Brennan, B. "Extracranial rhabdoid tumours: what we have learned so far and future directions." Lancet oncology 14.8 (2013).
description	18.	MuÃoz-Pinedo, C. "Exploiting tumor vulnerabilities: epigenetics, cancer metabolism and the mTOR pathway in the era of Personalized Medicine." Cancer research 73.14 (2013): 4185-4189.
description	19.	Chan, C N. "Recent developments in human immunodeficiency virus-1 latency research." Journal of general virology 94.PART 5 (2013): 917-932.
description	20.	Nelson, V. "Next generation of mammalian target of rapamycin inhibitors for the treatment of cancer." Expert opinion on investigational drugs 22.6 (2013): 715-22.